Paliperidone in an adult patient with asperger syndrome: Case report

Pharmacopsychiatry

Volumn 42, Issue 2, 2009, Pages 78-79

  Roser, P ^a   Haussleiter I S ^a   Juckel, G ^a   Brune M ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PALIPERIDONE; 9 HYDROXY RISPERIDONE; 9-HYDROXY-RISPERIDONE; ISOXAZOLE DERIVATIVE; NEUROLEPTIC AGENT; PYRIMIDINE DERIVATIVE;

ABSENCE OF SIDE EFFECTS; ADULT; AGORAPHOBIA; ANXIETY; ARTICLE; ASPERGER SYNDROME; AUTISM; CASE REPORT; COMPULSION; DELUSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE SEVERITY; DRUG FORMULATION; DRUG RELEASE; DRUG TOLERABILITY; HUMAN; HYPOCHONDRIASIS; IRRITABILITY; MALE; NONVERBAL COMMUNICATION; PRIORITY JOURNAL; PSYCHOSIS; RESTLESSNESS; SLEEP DISORDER; SOCIAL INTERACTION; SOCIAL ISOLATION; STEREOTYPY; HUMAN RELATION; LETTER; PSYCHOLOGICAL ASPECT;

ADULT; ANTIPSYCHOTIC AGENTS; ANXIETY; ASPERGER SYNDROME; DELUSIONS; HUMANS; INTERPERSONAL RELATIONS; ISOXAZOLES; MALE; PYRIMIDINES;

EID: 67649227101     PISSN: 01763679     EISSN: 14390795     Source Type: Journal    
DOI: 10.1055/s-0028-1102913     Document Type: Article

References (14)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC, American Psychiatric Association ; 1994
2. Badcock C, Crespi B. Imbalanced genomic imprinting in brain development: an evolutionary basis for the aetiology of autism. J Evol Biol 2006 ; 19 : 1007-1032
3. Gillberg C, Billstedt E. Autism and Asperger syndrome: coexistence with other clinical disorders. Acta Psychiatr Scand 2000 ; 102 : 321-330
4. Kamp-Becker I, Mattejat F, Wolf-Ostermann K et al. The Marburg Rating Scale for Asperger's Syndrome (MBAS) - a screening instrument for high-functioning autistic disorders. Z Kinder Jugendpsychiatr Psychother 2005 ; 33 : 15-26
5. Lautenschlager M, Heinz A. Paliperidone-ER: fi rst atypical antipsychotic with oral extended release formulation. Expert Rev Neurother 2008 ; 8 : 193-200
6. Leon J, Susce MT, Pan RM et al. A study of genetic (CYP2D6 and ABCB1) and environmental (drug inhibitors and inducers) variables that may infl uence plasma risperidone levels. Pharmacopsychiatry 2007 ; 40 : 93-102
7. Lindstrom LH, Gefvert O, Hagberg G et al. Increased dopamine synthesis rate in medial prefrontal cortex and striatum in schizophrenia indicated by L-(beta-11C) DOPA and PET. Biol Psychiatry 1999 ; 46 : 681-688
8. MacCracken JT, MacGough J, Shah B et al. Risperidone in children with autism and serious behavioral problems. N Engl J Med 2002 ; 347 : 314-321
9. Megens AA, Awouters FH. In vivo pharmacological profi le of 9-hydroxyrisperidone, the major metabolite of the novel antipsychotic risperidone . Drug Dev Res 1994 ; 33 : 399-412
10. Nieminen-von Wendt T, Mets ähonkala L, Kulom ä ki TA et al. Increased presynaptic dopamine function in Asperger syndrome. NeuroReport 2004 ; 15 : 757-760
11. Nieminen-von Wendt T, Salonen O, Vanhala R et al. A quantitative controlled MRI study of the brain in 28 persons with Asperger syndrome. Int J Circumpolar Health 2002 ; 61 (Suppl 2) : 22-35
12. Nopoulos PC, Ceilley JW, Gailis EA et al. An MRI study of midbrain morphology in patients with schizophrenia: relationship to psychosis, neuroleptics, and cerebellar neural circuitry. Biol Psychiatry 2001 ; 49 : 13-19
13. Towbin KE. Strategies for pharmacological treatment of high functioning autism and Asperger syndrome. Child Adolesc Psychiatr Clin N Am 2003 ; 12 : 23-45
14. Ylisaukko-oja T, Nieminen-von Wendt T, Kempas E et al. Genomewide scan for loci of Asperger syndrome. Mol Psychiatry 2004 ; 9 : 161-168